For help on how to get the results you want, see our search tips.
10 results
Categories
Human Remove Human filter
-
List item
Orphan designation: (S)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium for: Treatment of pulmonary arterial hypertension
Date of designation: 29/05/2019, Positive, Last updated: 09/08/2019 -
List item
Orphan designation: (S)-5-(1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethylamino-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile for: Treatment of acute myeloid leukaemia
Date of designation: 29/05/2019, Positive, Last updated: 07/05/2020 -
List item
Orphan designation: Allogeneic skin-derived ABCB5-positive mesenchymal stem cells for: Treatment of epidermolysis bullosa
Date of designation: 29/05/2019, Positive, Last updated: 09/08/2019 -
List item
Orphan designation: Diacerein for: Treatment of epidermolysis bullosa
Date of designation: 29/05/2019, Positive, Last updated: 19/08/2019 -
List item
Orphan designation: Emixustat hydrochloride for: Treatment of Stargardt's disease
Date of designation: 29/05/2019, Positive, Last updated: 09/08/2019 -
List item
Orphan designation: Relacorilant for: Treatment of Cushing's syndrome
Date of designation: 29/05/2019, Positive, Last updated: 09/08/2019 -
List item
Orphan designation: Sodium phenylacetate, Sodium benzoate for: Treatment of citrullinaemia type 1
Date of designation: 29/05/2019, Positive, Last updated: 12/08/2019 -
List item
Orphan designation: Sodium benzoate for: Treatment of carbamoyl-phosphate synthase-1 deficiency
Date of designation: 29/05/2019, Positive, Last updated: 12/08/2019 -
List item
Orphan designation: N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide for: Treatment of cystic fibrosis
Date of designation: 29/05/2019, Withdrawn, Last updated: 30/07/2021 -
List item
Orphan designation: Zanubrutinib for: Treatment of lymphoplasmacytic lymphoma
Date of designation: 29/05/2019, Withdrawn, Last updated: 15/12/2021